Trinity Biotech is a publicly traded company trading on NASDAQ, led by CEO John Gillard.
Upcoming earnings announcement for Trinity Biotech
Past 11 earnings reports for Trinity Biotech
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q2 2025 | —Est: -$0.20 | — | —Est: $14.5M | — | — |
| Feb 13, 2026 | Q3 2025 | —Est: -$0.32 | — | —Est: $15.0M | — | — |
| Feb 13, 2026 | Q1 2025 | —Est: -$0.15 | — | —Est: $14.5M | — | — |
| May 15, 2025 | Q4 2024 | -$0.13Est: -$0.30 | +57.3% | $15.9MEst: $16.5M | -3.9% | — |
| Nov 15, 2024 | Q3 2024 | -$0.46Est: -$0.54 | +14.8% | $15.2MEst: $16.5M | -8.2% | — |
| Aug 14, 2024 | Q2 2024 | -$0.71 | — | $15.8M | — | — |
| May 23, 2024 | Q1 2024 | -$0.37 | — | $14.7M | — | — |
| Apr 4, 2024 | Q4 2023 | -$0.72Est: -$0.60 | -20.0% | $13.4MEst: $15.0M | -10.5% | — |
| Jan 31, 2024 | Q3 2023 | -$0.88Est: -$0.75 | -17.3% | $14.7MEst: $14.5M | +1.2% | — |
| Oct 3, 2023 | Q2 2023 | -$0.80Est: -$0.45 | -77.8% | $13.9MEst: $13.5M | +2.9% | — |
| Jul 6, 2023 | Q1 2023 | -$0.76Est: -$0.30 | -153.3% | $14.8MEst: $18.5M | -19.8% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.